Only registred members can create thier own customized alerts.
-
27/04/10
Rick Soni of Rexahn Pharmaceuticals talks about Serdaxin as an anti-depressant, a partnership with T -
15/04/10
Rexahn Pharmaceuticals to present pre-clinical data for anti-cancer compound at AACR Annual Meeting -
14/04/10
Rexahn Pharmaceuticals clarifies purpose and results of Serdaxin clinical trial -
06/04/10
Rexahn Pharmaceuticals submits Phase II study protocol for Serdaxin to US FDA -
01/04/10
What’s All the Excitement About Rexahn Pharmaceuticals? -
29/03/10
Rexahn Pharmaceuticals discovery platform continues to churn out potential blockbuster compounds -
23/03/10
Rexahn Pharma sets up advisory board to assist with anti-Parkinson’s drug development -
11/03/10
Rexahn Pharma secures Japanese patent for anti-cancer drug Archexin